A clinical-stage company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases is among the three new biotech stocks to watch.
Among the three top biotech stocks to buy right now, as identified by the author of today’s article, is a company that he argues “deserves… Read More »“The Overall Best Biotech Around” – And 2 Other Top Biotech Stock Picks
Is the current downturn a good buying opportunity for biotech stocks? And, if so, which biotech stocks are the most promising picks for aggressive investors?
Two penny stocks that boast “Strong Buy” consensus ratings from the analyst community and massive upside potential.
A clinical-stage biotech company focused on developing tumor-specific immunotherapies to fight multiple cancer types and which is also developing a COVID-19 vaccine that could aid in the battle against variant strains of the virus.
Covid-19 vaccines aren’t the only ones you should be paying attention to” – and they highlight seven “second-tier” biotechs with catalysts beyond COVID-19 vaccines that may be worth considering.
Two clinical-stage biotech stocks with the potential to deliver gains of 100% or more.
What makes the genetic testing and sequencing company featured in today’s article potentially the best coronavirus stock investors can buy right now?
As a result of rising demand, artificial intelligence, increasing partnerships and scientific breakthroughs, Deloitte declared in a January report that the life sciences industry, including biotechnology, will be “stronger than ever” in 2021.
The company featured in today’s article finds itself at the intersection of biotech and cannabis – an intersection that could be worth $50 billion by 2029.